Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

Ornipressin

From Wikipedia, the free encyclopedia
Ornipressin
Names
IUPAC name
(2S)-N-[(2S)-5-Amino-1-[(2-amino-2-oxoethyl)amino]- 1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)- 19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl] -6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17- pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard100.020.231Edit this at Wikidata
MeSHOrnipressin
UNII
  • InChI=1S/C45H63N13O12S2/c46-16-4-8-28(39(64)51-21-37(50)62)53-44(69)34-9-5-17-58(34)45(70)33-23-72-71-22-27(47)38(63)54-30(19-25-10-12-26(59)13-11-25)42(67)55-31(18-24-6-2-1-3-7-24)41(66)52-29(14-15-35(48)60)40(65)56-32(20-36(49)61)43(68)57-33/h1-3,6-7,10-13,27-34,59H,4-5,8-9,14-23,46-47H2,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,69)(H,54,63)(H,55,67)(H,56,65)(H,57,68)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1 checkY
    Key: MUNMIGOEDGHVLE-LGYYRGKSSA-N checkY
  • InChI=1/C45H63N13O12S2/c46-16-4-8-28(39(64)51-21-37(50)62)53-44(69)34-9-5-17-58(34)45(70)33-23-72-71-22-27(47)38(63)54-30(19-25-10-12-26(59)13-11-25)42(67)55-31(18-24-6-2-1-3-7-24)41(66)52-29(14-15-35(48)60)40(65)56-32(20-36(49)61)43(68)57-33/h1-3,6-7,10-13,27-34,59H,4-5,8-9,14-23,46-47H2,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,69)(H,54,63)(H,55,67)(H,56,65)(H,57,68)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1
    Key: MUNMIGOEDGHVLE-LGYYRGKSBZ
  • NC(=O)CNC(=O)[C@H](CCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H]4NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC4)CC(N)=O
Properties
C45H63N13O12S2
Molar mass1042.19 g/mol
Pharmacology
H01BA05 (WHO)
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Chemical compound

Ornipressin is avasoconstrictor,[1][2]haemostatic andrenal agent.

References

[edit]
  1. ^H. Fruhstofer, M.D., M. Heisler, M.D. (1994)."Dose-response relation of ornipressin with regard to vasoconstriction in human skin".Br. J. Anaesth.73 (2):220–224.doi:10.1093/bja/73.2.220.PMID 7917739.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^Marc De Kock, MD, Pierre-Francois Laterre, MD, Patricia Andruetto, MD, Lionel Vanderessen, MD, Sylvie Dekrom, MD, Bernard Vanderick, MD and Patricia Lavand’homme, MD (June 2000)."Ornipressin (Por 8): An Efficient Alternative to Counteract Hypotension During Combined General/Epidural Anesthesia".Anesthesia & Analgesia.90 (6):1301–1307.doi:10.1097/00000539-200006000-00008.PMID 10825311.S2CID 44936158.{{cite journal}}: CS1 maint: multiple names: authors list (link)


Oxytocin
Vasopressin
V1A
V1B
V2
Unsorted
Others


Stub icon

Thishormonal preparation article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ornipressin&oldid=1170119102"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp